QuidelOrtho Corp·4

Feb 10, 4:09 PM ET

Busky Joseph M. 4

4 · QuidelOrtho Corp · Filed Feb 10, 2026

Research Summary

AI-generated summary of this filing

Updated

QuidelOrtho CFO Joseph Busky Receives RSUs, Sells 1,806 Shares

What Happened Joseph M. Busky, Chief Financial Officer of QuidelOrtho Corporation (QDEL), had 5,968 restricted stock units (RSUs) release and convert into common shares on February 8, 2026. Those converted RSUs were issued at $0 (vesting/conversion). To satisfy tax withholding on the issuance, 1,806 of the shares were withheld/sold at $29.10 per share, generating proceeds of $52,555. The underlying RSUs were reported as exercised/converted (derivative transaction) and as an award/acquisition upon vesting.

Key Details

  • Transaction date: February 8, 2026 (filed Feb 10, 2026).
  • Shares issued on vesting: 5,968 RSUs converted to 5,968 common shares (acquired at $0).
  • Shares withheld/sold for taxes: 1,806 shares at $29.10, proceeds $52,555.
  • Footnotes: RSU release previously reported; withholding was used to satisfy tax obligations; 1 RSU = 1 share.
  • Vesting schedule: 5,968 shares vested on Feb 8, 2025 and 5,968 on Feb 8, 2026; remaining 5,969 RSUs vest on Feb 8, 2027.
  • Shares owned after transaction: Not specified in the provided excerpt.
  • Filing timeliness: No late filing indicated in the provided data.

Context This was a standard RSU vesting and tax-withholding transaction (common for executives). The conversion of RSUs to shares followed by share withholding to cover taxes is routine and does not by itself indicate a discretionary open-market sale or buy decision.

Insider Transaction Report

Form 4
Period: 2026-02-08
Busky Joseph M.
Chief Financial Officer
Transactions
  • Award

    Common Stock

    [F1]
    2026-02-08+5,96843,218 total
  • Tax Payment

    Common Stock

    [F2]
    2026-02-08$29.10/sh1,806$52,55541,412 total
  • Exercise/Conversion

    Restricted Stock Units

    [F3][F4]
    2026-02-085,9685,969 total
    Common Stock (5,968 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    6,920
Footnotes (4)
  • [F1]Reflects release of restricted stock units that were previously reported on a Form 4.
  • [F2]Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.
  • [F3]Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
  • [F4]5,968 shares vested on each of February 8, 2025 and February 8, 2026; and the remaining 5,969 shares will vest on February 8, 2027.
Signature
/s/ Phillip S. Askim, attorney-in-fact for Joseph M. Busky|2026-02-10

Documents

1 file
  • 4
    wk-form4_1770757795.xmlPrimary

    FORM 4